Upper extremity deep venous thrombosis in cancer patients with venous access devices - Prophylaxis with a low molecular weight heparin (Fragmin)

Thrombosis and Haemostasis

Volumn 75, Issue 2, 1996, Pages 251-253

  Monreal, Manuel ^a   Alastrue, Antoni ^a   Rull, Miquel ^a   Mira, Xavier ^a   Muxart, Jordi ^a   Rosell, Rafael ^a   Abad, Albert ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARM; ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS CATHETER; MALE; PHLEBOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT;

EID: 0029985941     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650254     Document Type: Article

References (16)

1. Hill SL, Berry RE. Subclavian vein thrombosis: A continuing challenge. Surgery 1990; 108: 1-9.
2. Wechsler RJ, Spim PW, Conant EF, Steiner RF, Needleman L. Thrombosis and infection caused by thoracic venous catheters: Pathogenesis and imaging findings. AJR 1993; 160: 467-71.
3. Haire WD, Lieberman RP, Edney J, Vaughan WP, Kessinger A. Armitage JO, Goldsmith JC. Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 1990; 66: 900-8.
4. Monreal M, Lafoz E, Casals A, Ruiz J, Arias A. Platelet count and venous thromboembolism A useful test for suspected pulmonary embolism. Chest 1991; 100: 1493-6.
5. Monreal M, Lafoz E, Ruiz J, Gimenez G. Platelet count in acute pulmonary embolism: its relationship to recurrences. Haemostasis 1993; 23: 263-8.
6. Monreal M, Lafoz E, Roca J, Granero X, Soler J, Salazar X, Olazabal A, Bergqvist D. Platelet count, antiplatelet therapy and pulmonary embolism. A prospective study in patients with hip surgery. Thromb Haemost 1995; 73: 380-5.
7. Alastrue A, Rull M, Escudero LE, Moral P, Gelonch J, Carles J, Flores A, Rosell R, Broggi MA. Experiencia con 150 reservorios venosos subcutáneos como acceso venoso e infusión de tratamiento en pacientes adultos oncológicos, hematológicos y afectos de síndrome de inmunodeficiencia adquirida. Med Clin 1992; 99: 444-9.
8. Gelonch J, Alastrue A, Ribera JM. Reservorios venosos subcutáneos. Med Clin 1992; 99: 465-70.
9. Horattas MC, Wright DJ, Fenton AH, Evans DM, Oddi MA, Kamienski RW, Shields EF. Changing concepts of deep venous thrombosis of the upper extremity. Report of a series and review of the literature. Surgery 1988; 104: 561-7.
10. Monreal M, Lafoz E, Ruiz J, Valls R, Alastrue A. Upper extremity deep-venous thrombosis and pulmonary embolism. A prospective study. Chest 1991; 99: 280-3.
11. Monreal M, Raventos A, Lerma R, Ruiz J, Lafoz E, Alastrue A, Llamazares JF. Pulmonary embolism in patients with upper-extremity DVT associated to venous central lines. A prospective study. Thromb Haemost 1994; 72 (4): 548-50.
12. Anderson AJ, Krasnow SH, Boyer MW, Cutler DJ, Jones BD, Citron ML, Ortega LG, Cohen MH. Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest 1989; 95: 71-5.
13. Starkhammar H, Bengtsson M, Morales O. Fibrin sleeve formation after long term brachial catheterisation with an implantable port device. A prospective venographic study. Eur J Surg 1992; 158: 481-4.
14. Home MDK, Mayo DJ, Alexander R, Steinhaus EP, Chang RC, Whitman E, Gralnick HR. Upper extremity impedance plethysmography in patients with venous access devices. Thromb Haemost 1994; 72: 540-2.
15. Bern MM, Lokich JJ, Wallach SR, Bothe A, Benotti PN, Arkin CF, Greco FA, Huberman M, Moore C. Very low doses of warfarin can prevent thrombosis in central venous catheters A randomized prospective trial. Ann Intern Med 1990; 112: 423-8.
16. Levine M, Hirsh J, Gent M, Arnold A, Warr D, Falanga A, Samosh M, Bramwell V, Pritchard K, Stewart D, Goodwin P. Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 1994; 343: 886-9.